TickerFacts.

Abvc Biopharma, Inc. (ABVC): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2011-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$21.2K
Year ended 2023-12-31
$119.7K2010-09-30: -$1.4K2011-09-30: $29.8K2012-09-30: $3502013-09-30: $02021-12-31: $17.5K2022-12-31: $119.7K2023-12-31: $21.2K$21.2K
2010-09-30 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$21.2K-82.3%2025-04-15, From 2023-01-01
2022-12-31$119.7K+583.8%2024-03-13, From 2022-01-01
2021-12-31$17.5Kn/a2023-03-31, From 2021-01-01
No annual figure between 2013-09-30 and 2021-12-31.
2013-09-30$0-100.0%2015-04-16, From 2012-10-01
2012-09-30$350-98.8%2015-04-16, From 2011-10-01
2011-09-30$29.8Kn/c2015-04-15, From 2010-10-01
2010-09-30-$1.4Kn/a2011-12-28, From 2009-10-01